These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
631 related items for PubMed ID: 25515355
21. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? Rossom RC, Rector TS, Lederle FA, Dysken MW. J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081 [Abstract] [Full Text] [Related]
22. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis. Lin YT, Hwang TJ, Shan JC, Chiang HL, Sheu YH, Hwu HG. J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176 [Abstract] [Full Text] [Related]
24. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission. Valevski A, Gilat Y, Olfson M, Benaroya-Milshtein N, Weizman A. Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059 [Abstract] [Full Text] [Related]
25. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users. Barnett MJ, Wehring H, Perry PJ. J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126 [Abstract] [Full Text] [Related]
27. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA. BMC Psychiatry; 2009 May 16; 9():24. PubMed ID: 19445700 [Abstract] [Full Text] [Related]
28. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics. Ng-Mak D, Messali A, Huang A, Wang L, Loebel A. Am J Manag Care; 2019 Jul 16; 25(14 Suppl):S279-S286. PubMed ID: 31365818 [Abstract] [Full Text] [Related]
29. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. Schizophr Bull; 2006 Oct 16; 32(4):715-23. PubMed ID: 16540702 [Abstract] [Full Text] [Related]
30. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M. J Clin Psychiatry; 1995 Oct 16; 56(10):466-70. PubMed ID: 7559373 [Abstract] [Full Text] [Related]
31. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona. Gaviria AM, Franco JG, Aguado V, Rico G, Labad J, de Pablo J, Vilella E. PLoS One; 2015 Oct 16; 10(10):e0139403. PubMed ID: 26427051 [Abstract] [Full Text] [Related]
32. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis. Ayenew W, Asmamaw G, Bitew T. Int J Neuropsychopharmacol; 2021 Dec 08; 24(12):956-964. PubMed ID: 34245271 [Abstract] [Full Text] [Related]
40. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. Malla AK, Norman RM, Scholten DJ, Zirul S, Kotteda V. J Clin Psychiatry; 2001 Mar 08; 62(3):179-84. PubMed ID: 11305704 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]